Open Mobile Menu
2022 Cancer and Blood Diseases Institute Accomplishments Report
Contact Us
Close Mobile Menu
Overview
Accomplishments
World’s First FLASH Proton Therapy Clinical Trial Shows Promising Results
Inotuzumab Leads to Remission in 58% of Children with Relapsed/Refractory B-ALL
Seminal Study Reveals a Hidden Culprit in the Development of Adult Blood Cancers
Study Highlights the Benefits of Hydroxyurea Therapy for Children with Sickle Cell Disease to Doctors, Public Health Leaders in Jamaica
Gene Study Reveals Which Patients with Shwachman-Diamond Syndrome are at High Risk for Leukemia
Could FLASH Radiation Transform Cancer Therapy? Research from the Cincinnati Children’s Proton Therapy Center May Provide Answers
Meet Our Team
Program Data
Facebook
Twitter
Email
Program Data
Overall FY22 Data (July 2021 through June 2022)
